Skip to main content
. 2022 Jan 4;24(3):497–509. doi: 10.1002/ejhf.2403

Figure 3.

EJHF-2403-FIG-0003-c

Effect of sacubitril‐valsartan, compared with valsartan, on the primary composite outcome (cardiovascular death and total heart failure hospitalizations) across the range of glycated haemoglobin (HbA1c) 5% to 9%. The green line is the rate ratio; the red line is the line of unity; the grey shaded area represents the 95% confidence interval.